Mike Cintolo
Cabot Top Ten Trader
Geoffrey Seiler
Bullmarket.com
Sy Harding
Street Smart Report
Nicholas Vardy
Bull Market Alert

Four standouts for growth and income


Bookmark and Share
by Richard Moroney, editor Dow Theory Forecast

Richard MoroneyIn good times or bad, dividend increases make a difference. A history of dividend increases suggests a company possesses financial fortitude and a commitment to sharing the wealth with stockholders.

We've found four standouts that have shown steady dividend increases, with three-year annualized growth rates of at least 9%: Abbott Laboratories (ABT), Dover (DOV), IBM (IBM) and Microsoft (MSFT).

These found stocks are also expected to grow per-share earnings this year and in each of the next two years.

Abbott has increased its quarterly dividend in 39 consecutive years. In the past three years, the dividend has grown at an annualized rate of 10%, topping the other big U.S. drug companies.

The stock, up 12% this year, offers a 3.5% yield, exceeding its five- year average of 3.0%.

The dividend, however, will undergo a shift from its present form next year when Abbott splits its pharmaceutical unit ($18 billion in sales) from the rest of its businesses ($20 billion).

Both companies will pay a dividend, and taken together, their distributions should equal Abbott’s dividend at the time of the separation.

Backstopped by strong balance sheets, both new companies should also receive investment-grade credit ratings, Abbott says.

Some speculate that the new pharmaceutical company could receive a heftier portion of debt and cash, since the medical-devices business will likely be better equipped to generate free cash flow. Abbott Labs is a Long-Term Buy.

Dover, an industrial conglomerate, makes everything from hydraulic lifts to refrigeration systems to hearing-aid components.


Order activity remained strong in the opening weeks of the December quarter, management says, building on the 20% increase in bookings during the September quarter.

Dover anticipates revenue will climb 20% in 2011, bolstered by at least 8% organic growth in all four segments. Free cash fl ow is on pace to represent 10% to 11% of revenue for the year.

That implies a record $856 million to $941 million in free cash flow, marking the strongest growth since 2003. That cash will likely fund Dover’s steady stream of dividend hikes and acquisitions.

Dover announced a 15% dividend increase in August, marking its 56th consecutive year of dividend growth. Dover has also purchased at least eight companies so far this year, spending more than $1.37 billion.

In its latest deal, completed in November, Dover acquired Advansor A/S of Denmark to expand its presence in the refrigeration-equipment market. Dover is a Long-Term Buy.  

IBM uses a two- pronged approach for sharing profi ts with stockholders. The dividend has grown for 16 straight years, including a 15% hike in May.

The tech giant has raised its payout at an annualized rate of 26% over the last fi ve years, well above its growth rate for per-share profits (17%) and operating cash flow (5%).

IBM also has a seemingly insatiable appetite for its own stock, buying back enough to lower the share count 5% over the last year and 21% over the last five years.

Looking ahead, IBM seems capable of returning even more cash to share- holders. Despite the steady dividend growth, IBM’s payout ratio is a modest 23% of trailing earnings.

Management expects $100 billion in free cash flow over the next fi ve years, translating to 12% growth from the previous five years.

Roughly 70% of that cash should return to shareholders through dividends and buybacks. IBM is a Long-Term Buy.

Microsoft raised its dividend 25% in September, nearly double its five-year annual growth rate.

The dividend hike pushed Microsoft’s yield to 2.9%, well above the 2.0% average for dividend- paying technology stocks in the S&P 500 Index.

The company has $11.2 billion remaining from a $40 billion share-repurchase program launched in 2008. That balance is enough to buy back about 5% of outstanding shares at current prices.

In the past year, Microsoft has spent $5.4 billion in dividends and $8.5 billion on repurchases.

Yet Microsoft’s massive cash hoard still gives it plenty of flexibility. The software giant generated $19.66 billion in free cash flow in the 12 months ended September.

It now holds $57.40 billion in cash and short-term investments — though roughly 90% is offshore — versus long-term debt of $11.92 billion.

Net cash equals $5.36 per share, roughly 20% of the stock price. Microsoft is a Buy and a Long- Term Buy.

Learn more about this financial newsletter at Richard Moroney's Dow Theory Forecasts.

Advertisement
Banner
News Flash

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...


   

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 

Tesla: 'Out of the ball park'
by Timothy Lutts. editor Cabot Stock of the Month

Tesla (TSLA), our previously featured Stock of the Month and our top stock pick for 2013, knocked the ball out of the park in its latest quarter. The company exceeded analysts' expectations on all counts: cars sold, revenues, earnings, gross margins and more.


Read more...

 

5 ways to speculate on Cuba
by Jim Powell, editor Global Changes & Opportunities Report

With the death of Hugo Chavez in March, and Venezuela’s economic decline, the heavily subsidized oil lifeline is likely to be cut or sharply reduced. I think the resulting energy squeeze will force Cuba to allow greater foreign trade and investment.


Read more...

 

Big gains in nanotechnology?
by Doug Fabian, editor Making Money Alert

The nanotechnology niche focuses on very small, even microscopic, technology. Nanotech has produced technological developments in medicine (lasers), electronics (ink jet systems) and biomaterials (chemical and bio-detectors).


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary